Sulindac NDC 24658-770

NDC codes

FDA NDC Directory

Product NDC (as listed)24658-770Labeler and product segments. Claims need a package NDC.

Product NDC at billing width24658-0770Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
24658-770-01	24658077001	100 TABLET in 1 BOTTLE (24658-770-01)Marketed from Nov 14, 2016
24658-770-05	24658077005	500 TABLET in 1 BOTTLE (24658-770-05)Marketed from Nov 14, 2016

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Sulindac
Generic name (nonproprietary): sulindac
Active ingredients: Sulindac — 150 mg/1
Dosage form: Tablet
Route: Oral
Labeler: PuraCap Laboratories LLC dba Blu Pharmaceuticals
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 072710
Marketing start: Nov 14, 2016
Listing expires: Dec 31, 2026
Other FDA classes: Non-Steroidal (Chemical structure)Cyclooxygenase Inhibitors (Mechanism)
Identifiers: Product ID 24658-770_cb28dfa2-28af-47a2-ab7f-1c65720d9496SPL ID cb28dfa2-28af-47a2-ab7f-1c65720d9496SPL set ID 0feabf47-8d0d-48c0-b263-43db4969f39eRxCUI 198238, 198239UNII 184SNS8VUHUPC 0324658771014, 0324658770055
Pharmacologic class: Nonsteroidal Anti-inflammatory Drug

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N424658077001 followed by a unit qualifier and the quantity

Package 24658-0770-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 11, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE Carefully consider the potential benefits and risks of sulindac and other treatment options before deciding to use sulindac. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see WARNINGS ). Sulindac is indicated for acute or long-term use in the relief of signs and symptoms of the following: 1. Osteoarthritis 2. Rheumatoid arthritis** 3. Ankylosing spondylitis 4. Acute painful shoulder (Acute subacromial bursitis/supraspinatus tendinitis) 5. Acute gouty arthritis **The safety and effectiveness of sulindac tablets USP have not been established in rheumatoid arthritis patients who are designated in the American Rh…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 072710

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 072710
Product	Strength	Form · route	Labeler	Product NDC
Sulindac	Sulindac 150 mg/1	TabletOral	Epic Pharma, LLC	42806-018